News Listing

Tumour-trained T cells go on patrol

Tumour-trained T cells go on patrol

MEDIA RELEASE: May 16, 2017 10:42 PM
‘Tumour-trained’ immune cells – which have the potential to kill cancer cells – have been seen moving from one tumour to another for the first time. The new findings, which were uncovered by scientists at Sydney’s Garvan Institute of Medical Research, shed light on how immune therapies for cancer might work, and suggest new approaches to developing anti-cancer immune therapies.

More…

PKD Australia funding to help develop diagnostic tool for kidney disease

PKD Australia funding to help develop diagnostic tool for kidney disease

May 12, 2017 08:00 AM
Garvan researcher Dr Amali Mallawaarachchi has been awarded a grant from the Polycystic Kidney Disease Foundation of Australia to support the development of an improved genomic diagnostic tool for individuals with kidney disease.

More…

Love Your Sister's Big Heart Project raises over $2 million for cancer research

Love Your Sister's Big Heart Project raises over $2 million for cancer research

May 11, 2017 02:52 PM
History was made in Canberra yesterday, when the Big Heart Project, an initiative of Love Your Sister, raised a remarkable $2.2 million for cancer research at Garvan.

More…

Proteins on the loose in a debilitating childhood disease

Proteins on the loose in a debilitating childhood disease

MEDIA RELEASE: May 11, 2017 12:05 AM
Australian scientists have shown, for the first time, that a family of untethered proteins builds up in the cells of children with a rare and serious genetic condition, known as mevalonate kinase deficiency (MKD).

More…

Annual awards celebrate key Garvan researchers

Annual awards celebrate key Garvan researchers

May 09, 2017 06:00 AM
Garvan congratulates Dr Thomas Cox, Dr Simon Junankar, Dr Romain Rouet and Dr Sean Warren, winners of the annual Ridley Ken Davies Award, CHAMP Young Pioneer Award and the Palmer Innovation Prize.

More…

TRACEBACK for change in ovarian cancer

TRACEBACK for change in ovarian cancer

MEDIA RELEASE: May 08, 2017 06:00 AM
Australian women diagnosed with ovarian cancer before 2013, and their families, will be proactively identified and offered genetic testing for the BRCA1 and BRCA2 genes through a new international study, ‘TRACEBACK’.

More…

From basic research to the clinic: reflections on a key immunology conference

From basic research to the clinic: reflections on a key immunology conference

May 06, 2017 11:14 AM
Last week (April 24-28), immunologists from round the world converged on Whistler (BC, Canada) for a Keystone Meeting on B Cells and T Follicular Helper Cells – the cells in our immune system that are crucial for long-term protection against infection, and for the success of most vaccines.

More…

Professor Jonathan Sprent elected to US National Academy of Sciences

Professor Jonathan Sprent elected to US National Academy of Sciences

May 04, 2017 04:07 PM
Garvan congratulates Professor Jonathan Sprent, of the Institute’s Immunology Division, who has been newly elected as a member of the US National Academy of Sciences (NAS). Membership of the NAS is considered one of the highest honours that a scientist can achieve.

More…

John Mattick: Whole genome sequencing is medicine’s Snowy Scheme

John Mattick: Whole genome sequencing is medicine’s Snowy Scheme

Apr 13, 2017 07:03 PM
In this opinion piece in The Australian, Garvan's Executive Director, Professor John Mattick AO FAA says that Australia could be a front runner in precision medicine – but we need to act now.

More…

Science and art collaborate on visualising biological data during Vivid Sydney

Science and art collaborate on visualising biological data during Vivid Sydney

MEDIA RELEASE: Apr 11, 2017 03:32 PM
Garvan, CSIRO’s Data61, and the Charles Perkins Centre at The University of Sydney are joining forces for a series of events held as part of Vivid Sydney, showcasing visualisations that are transforming how life scientists view data and communicate discoveries.

More…

Mapping the genome of prostate cancer uncovers a new world of DNA rearrangements

Mapping the genome of prostate cancer uncovers a new world of DNA rearrangements

MEDIA RELEASE: Apr 11, 2017 12:53 PM
Researchers have ‘mapped’ the entire genome of a prostate tumour, revealing previously undetected levels of DNA rearrangements. The findings, from the Garvan Institute of Medical Research, provide an entirely new lens through which to view prostate cancer – and could one day be used to help characterise an individual’s prostate tumour and reveal previously unrecognised information that could influence clinical treatment.

More…

Garvan Institute marks 200th anniversary of Parkinson’s disease

Garvan Institute marks 200th anniversary of Parkinson’s disease

MEDIA RELEASE: Apr 11, 2017 07:22 AM
Today, World Parkinson’s Day marks 200 years since the disease was first identified by Dr James Parkinson.

More…

 World Parkinson's Day: “Fish with Parkinson’s” uncover a druggable pathway

World Parkinson's Day: “Fish with Parkinson’s” uncover a druggable pathway

MEDIA RELEASE: Apr 11, 2017 05:45 AM
Australian scientists have developed a first-of-its-kind model of Parkinson’s disease in zebrafish. In the model, neurodegeneration occurs through a combination of genetic and environmental factors – just as it does in people.

More…

Garvan and Asan Medical Center sign agreement to advance genomic medicine in cancer

Garvan and Asan Medical Center sign agreement to advance genomic medicine in cancer

Apr 10, 2017 11:47 AM
The Garvan Institute of Medical Research and the Asan Medical Center Cancer Institute in Seoul, South Korea, have signed a Memorandum of Understanding (MOU), formalising a cooperative relationship between the two institutes in the areas of research, clinical trials and education.

More…

“The best tool of its kind in the world”: Patient Archive being used to advance diagnosis of rare diseases in WA

“The best tool of its kind in the world”: Patient Archive being used to advance diagnosis of rare diseases in WA

MEDIA RELEASE: Apr 07, 2017 02:00 AM
Western Australia’s Undiagnosed Diseases Program (UDP) has acquired Patient Archive clinical phenotyping software from the Garvan Institute of Medical Research.

More…

A one-two punch for pancreatic cancer: ‘softening’ tumours before chemo markedly improves survival

A one-two punch for pancreatic cancer: ‘softening’ tumours before chemo markedly improves survival

MEDIA RELEASE: Apr 06, 2017 04:00 AM
Australian scientists have uncovered a promising new approach to treating pancreatic cancer, by targeting the tissue around the tumour to make it ‘softer’ and more responsive to chemotherapy. The findings are published today in Science Translational Medicine.

More…

Garvan and Deakin University join forces to accelerate precision medicine through machine learning

Garvan and Deakin University join forces to accelerate precision medicine through machine learning

MEDIA RELEASE: Mar 28, 2017 04:00 AM
The Garvan Institute of Medical Research and the Centre for Pattern Recognition and Data Analytics (PRaDA) at Deakin University will today launch the Garvan-Deakin Program in Advanced Genomic Investigation (PAGI).

More…

Drug Development Conference 2017: Collaboration is key to faster delivery of new cancer treatments

Drug Development Conference 2017: Collaboration is key to faster delivery of new cancer treatments

Mar 24, 2017 03:09 PM
Worlds collide in the landmark Drug Development Conference 2017 which brings together diverse parties that share one aim: to accelerate the delivery of new cancer drugs to patients.

More…

Garvan breast cancer researcher awarded 10-year Endowed Chair

Garvan breast cancer researcher awarded 10-year Endowed Chair

Mar 23, 2017 03:25 PM
Garvan congratulates Associate Professor Elgene Lim, who is one of two inaugural recipients of the National Breast Cancer Foundation Endowed Chair Program.

More…

Cancer Council NSW funding kickstarts research into colorectal cancer, breast cancer and osteosarcoma

Cancer Council NSW funding kickstarts research into colorectal cancer, breast cancer and osteosarcoma

Mar 02, 2017 12:00 AM
Researchers from Garvan’s Cancer Division were last night awarded five Project Grants from Cancer Council NSW.

More…


© Garvan Institute 2013